october 26, 2019 - era-edta.org · october 25, 2019 october 26, 2019 new drugs in kidney disease...

2
The Scientific and Educational Interaction Day (SEID) is an exciting meeting which boasts educational lectures focused mainly on clinical issues, starting from diagnosis all the way to prevention and therapy. Sessions will focus on systemic diseases that affect the kidney (ANCA-associated vasculitis, lupus nephritis, anti-GBM disease), ethical aspects of using genetic results in clinical daily practice and its implications but also stimulating discussions on patients and nephrologists’ considerations on the choice among hemodialysis, peritoneal dialysis and transplantation, being the latter considered the best treatment option for ESKD, as well. A consistent part of the meeting is devoted to vascular access which includes a practical session involving demonstrations of ultrasound scanning and fistula imaging on real patients. All participants will have a chance to practise imaging under the supervision and guidance of experts. The SEID has multiple educational objectives. It gives you the chance to learn how to responsibly apply genetic testing; it provides updates of current approaches to the diagnosis and treatment of systemic diseases and shares data on ongoing studies and emerging treatment options. It discusses the possibilities to better predict patient survival depending on recipient characteristics (comorbidities) as well as donor quality scores (such as KDRI). All of this in one single event! Do not miss the “New Drugs in Kidney Disease Symposium” which is preceding the SEID on October 25, 2019. This half-day symposium is designed to be a fully educational experience with some ‘industry focus’: key European speakers will contribute in the sessions providing updates on recent studies related to the treatment of anaemia, hyperkalaemia and diabetes in CKD. Sessions will be available after the event as e-materials. How to register ERA-EDTA Members only (categories A, B and C) are entitled to participate in the meetings (October 25-26, 2019). Special membership fee: EUR 175.00. Pre-registration is highly reccomended (due to the limited number of seats). Cancellation is possible no later than August 31, 2019. Travel grant opportunities - The ERA-EDTA offers up to a max. amount of EUR 30,000.00 in Travel Grants to ERA-EDTA members (categories A and B) who are not older than 40 in 2019. Deadline for application is July 15, 2019. Please contact ERA-EDTA Group for Travel Grants and general information [email protected] for SEID special membership fee [email protected] Phone: +39 0521 989078 www.era-edta.org This event is organised in collaboration with October 26, 2019 8.30-18.00 Preceded by its satellite ‘New Drugs in Kidney Disease Symposium’ October 25, 2019 14.00-17.30 Vienna Hilton Danube Waterfront Grandwaterfront Hall 1-2-3 Vienna, Austria

Upload: nguyenduong

Post on 14-Aug-2019

214 views

Category:

Documents


0 download

TRANSCRIPT

The Scientific and Educational Interaction Day (SEID) is an exciting meeting which boasts educational lectures focused mainly on clinical issues, starting from diagnosis all the way to prevention and therapy. Sessions will focus on systemic diseases that affect the kidney (ANCA-associated vasculitis, lupus nephritis, anti-GBM disease), ethical aspects of using genetic results in clinical daily practice and its implications but also stimulating discussions on patients and nephrologists’ considerations on the choice among hemodialysis, peritoneal dialysis and transplantation, being the latter considered the best treatment option for ESKD, as well.A consistent part of the meeting is devoted to vascular access which includes a practical session involving demonstrations of ultrasound scanning and fistula imaging on real patients. All participants will have a chance to practise imaging under the supervision and guidance of experts.The SEID has multiple educational objectives. It gives you the chance to learn how to responsibly apply genetic testing; it provides updates of current approaches to the diagnosis and treatment of systemic diseases and shares data on ongoing studies and emerging treatment options. It discusses the possibilities to better predict patient survival depending on recipient characteristics (comorbidities) as well as donor quality scores (such as KDRI). All of this in one single event!Do not miss the “New Drugs in Kidney Disease Symposium” which is preceding the SEID on October 25, 2019. This half-day symposium is designed to be a fully educational experience with some ‘industry focus’: key European speakers will contribute in the sessions providing updates on recent studies related to the treatment of anaemia, hyperkalaemia and diabetes in CKD. Sessions will be available after the event as e-materials.How to register ERA-EDTA Members only (categories A, B and C) are entitled to participate in the meetings (October 25-26, 2019).Special membership fee: EUR 175.00. Pre-registration is highly reccomended (due to the limited number of seats). Cancellation is possible no later than August 31, 2019.Travel grant opportunities - The ERA-EDTA offers up to a max.amount of EUR 30,000.00 in Travel Grants to ERA-EDTA members(categories A and B) who are not older than 40 in 2019. Deadline for application is July 15, 2019.Please contact ERA-EDTA Group

for Travel Grants and general [email protected] SEID special membership [email protected] Phone: +39 0521 989078www.era-edta.org

This event is organised in collaboration with

October 26, 20198.30-18.00

Preceded by its satellite‘New Drugs in Kidney Disease Symposium’

October 25, 201914.00-17.30

Vienna Hilton Danube WaterfrontGrandwaterfront Hall 1-2-3

Vienna, Austria

October 25, 2019 October 26, 2019

New Drugs in Kidney DiseaseSymposium

Scientific and EducationalInteraction Day

8.30-10.00 Session 1 - Ethical aspects of genetic testing in kidney diseases Ethical aspects of using genetic results for clinical decision making Albertien van Eerde, Utrecht, The Netherlands Presymptomatic testing in ADPKD Tess Harris, London, United Kingdom Genomic testing as part of mainstream nephrology; lessons for practicing nephrologists Daniel Gale, London, United Kingdom 10.00-10.30 Break 10.30-12.00 Session 2 - Systemic diseases affecting the kidney Extrarenal involvement in SLE and its impact on the outcome of pts with LN Vladimir Tesar, Prague, Czech Republic Renal involvement in AAV and its treatment Annette Bruchfeld, Stockholm, Sweden Anti-GBM disease with and without lung hemorrhage Marten Segelmark, Lund, Sweden 12.00-13.15 Lunch 13.15-14.45 Session 3 - Is transplantation the best option in this patient with this donor kidney? Barriers for patients and nephrologists with respect to RRT modality choice Vianda Stel, Amsterdam, The Netherlands Older donor kidneys: how well do they really function and who should

receive them? Maria Pippias, Amsterdam, The Netherlands Is there always a survival benefit with transplantation? Rachel Hellemans, Antwerp, Belgium 14.45-15.15 Break 15.15-18.00 Session 4 - Vascular access: the practicalities of fistula imaging Brief introduction: ultrasound scanning in the context of fistulae Karen Stevenson, Glasgow, United Kingdom Practical demonstration of fistula imaging Jose Ibeas, Barcelona, Spain

This session includes a practical section involving demonstrations of ultrasound scanning and fistula imaging on real patients. All participants will have a chance to practise imaging under the supervision and guidance of experts.

13.00-14.00 Lunch 14.00-15.00 SGLT2 in diabetic and non-diabetic CKD

SGLT2-inhibition in diabetic CKD Gert Mayer, Innsbruck, Austria

SGLT2-inhibition in non-diabetic CKD Johannes Mann, Munich, Germany 15.00-16.00 Renal anemia and HIF

Intravenous iron for treatment of anemia in CKD Lucia Del Vecchio, Lecco, Italy

HIF stabilizers for treatment of anemia in CKD Kai Uwe Eckardt, Berlin, Germany 16.00-16.30 Break 16.30-17.30 RAAS and Hyperkalemia

The risk of hyperkaliemia in CKD and in heart failure Marie Evans, Stockholm, Sweden

New options for hyperkalemia treatment Giovambattista Capasso, Naples, Italy

Prinect PDF Report 18.00.045 - 1 - 22.05.2019 09:28:05

Sintesi documentoNome file: 19C0893_ERA_SEID_Depliant.pdfTitolo: -Applicazione: Adobe InDesign CS5 (7.0)Creato con: Adobe PDF Library 9.9Autore: -Creato il: 21.05.2019 16:35:53Modificato il: 22.05.2019 09:27:25Dimens. file: 7.8 MByte / 8020.5 KByteTrapping: NoOutput Intent: -PDF/X Versione: -Versione PDF: 1.6Numero di pagine: 2Formato documento: 320.82 x 230.82 mmFormato finale: 300.00 x 210.00 mm

Riassunto Errore Avviso Riparato InfoDocumento - - - -PDF/X - - - -Pagine - - - -Colori - - - -Caratteri - - - -Immagini - - - -Contenuto - - - -

Informazioni addizionaliImpostazioni utilizzate: qualify_standard

Selezioni cromatiche: 4CMYK

Spazi cromaticiDeviceCMYK / Separation / DeviceN

Caratteri: 6Calibri TrueType / WinAnsi / sottogruppo incorporatoHelvetica TrueType / WinAnsi / sottogruppo incorporatoMinionPro-Regular Type1 / WinAnsi / sottogruppo incorporatoTahoma TrueType / WinAnsi / sottogruppo incorporatoTahoma TrueType (CID) / Identity-H / sottogruppo incorporatoTahoma-Bold TrueType (CID) / Identity-H / sottogruppo incorporato

Prinect PDF Report 18.00.045 - 1 - 22.05.2019 09:28:10

Sintesi documentoNome file: 19C0893_ERA_SEID_Depliant.pdfTitolo: -Applicazione: Adobe InDesign CS5 (7.0)Creato con: Adobe PDF Library 9.9Autore: -Creato il: 21.05.2019 16:35:53Modificato il: 22.05.2019 09:28:07Dimens. file: 8.5 MByte / 8688.8 KByteTrapping: NoOutput Intent: -PDF/X Versione: -Versione PDF: 1.6Numero di pagine: 2Formato documento: 909.40 x 654.28 ptFormato finale: 850.39 x 595.28 pt

Riassunto Errore Avviso Riparato InfoDocumento - - - -PDF/X - - - -Pagine - - - -Colori - - - -Caratteri - - - -Immagini - - - -Contenuto - - - -

Informazioni addizionaliImpostazioni utilizzate: cmyk

Selezioni cromatiche: 4CMYK

Spazi cromaticiDeviceCMYK / Separation / DeviceN

Caratteri: 6Calibri TrueType / WinAnsi / sottogruppo incorporatoHelvetica TrueType / WinAnsi / sottogruppo incorporatoMinionPro-Regular Type1 / WinAnsi / sottogruppo incorporatoTahoma TrueType / WinAnsi / sottogruppo incorporatoTahoma TrueType (CID) / Identity-H / sottogruppo incorporatoTahoma-Bold TrueType (CID) / Identity-H / sottogruppo incorporato